of sodium-potassium-activated adenosine triphosphatase (Na-K-ATPase) is higher in the outer medulla of the kidney than in the cortex (7, 13) raises the question of the role this enzyme plays in sodium reabsorption by different segments of the nephron. It is well known that cardioactive steroids like ouabain, which specifically inhibit Na-K-ATPase in vitro, inhibit the reabsorption of sodium by the kidney. The natriuretic effect is best shown when large doses of the drug are infused directly into the renal artery, so as to minimize their toxic action on the heart (3, 9, 11, 20) . In order to clarify the functional significance of Na-K-ATPase within the kidney, we have attempted in the present experiments to produce maximal inhibition of Na-K-ATPase by infusing large doses of ouabain into the renal artery, while measuring several parameters of renal function under varied conditions. At the end of the experiment, the activity of Na-K-ATPase in kidney homogenates was correlated with the functional changes observed. The results suggest that Na-K-ATPase plays a prominent role in sodium reabsorption in the thick ascending limb of the loop of Henle and the distal convolution and a lesser role in the proximal tubule. All experiments were ended 60 min after the infusion of ouabain had been completed. The total dose of ouabain infused varied from 60 to 150 pg/kg. In most experiments, however, 72-96 pg/kg were given over the course of 60 min.
Three dogs that received doses of ouabain of 120-l 50 lug/kg were also treated with diphenylhydantoin, (Dilantin, Parke, Davis & Co.) to suppress cardiac arrhythmias that might have been elicited by this large amount of ouabain. Dilantin, 300 mg, was given just before, and 2.5 mg/min were given during and after the infusion of ouabain, through the end of the experiment, 60 min after discontinuing the ouabain infusion.
In five dogs ouabain-3H (New England Nuclear Corp.) was added to the ouabain infused so as to produce a final specific activity of 5. 3-22.5 &pmole. Tritium was measured with a Packard Tri-Carb liquid scintillation spectrometer in samples of plasma, urine, and kidney, the latter prepared as described below.
At the end of the experiment, both kidneys were rapidly relnoved and placed in ice-cold saline. After removing the capsule thev were weighed and sliced > separating cortex and outer (red) medulla, and homogenates were prepared for measurement of Na-K-ATPase activity. represented 10 % of the whole organ. The water contents of cortex and medulla were assumed to be 75.6 and 82.9 %, respectively, as documented in a previous report from this laboratory (12).
RESULTS
General efects of ouabain infusion. In most dogs, the intrarenal infusion of ouabain was well tolerated. When doses of ouabain above 100 pg/kg were given, ventricular extrasystoles appeared. Two dogs that had not received diphenylhydantoin died suddenlv 30 and 50 min after ouabain was / discontinued.
Changes in blood pressure during the course of the experiment were variable, the blood pressure ranging from 60 to 120 YO of control while ouabain was infused. When ouabain was discontinued, blood pressure usually remained at approximately the same level observed during the infusion; in two dogs, it rose. While ouabain was infused into the renal artery, glomerular filtration rate declined by approximately 50 %. In one-fourth of the experiments, this reduction was partially reversed after the ouabain infusion had been completed.
In the contralateral kidney, a decrease in filtration rate of 25-50 % was also observed. Fractional sodium excretion, as discussed in detail below, increased in all experirnents both in the infused and the contralateral kidneys, though to a much smaller extent in the latter. The natriuretic effect developed during the ouabain infusion and was maximal within the 60 min of observation that followed discontinuation of the ouabain infusion.
Na-K-ATPase was inhibited in the infused kidney after ouabain both in outer medulla, to the range of 31.8-4.4 pmoles Pi/mg protein per hour (22-89 YO inhibition) and in cortex, to the range of 4.8-0.4 pmoles Pi/ mg protein in kidney cortex and medulla were made in all; in three, the concentration of ouabain in kidney tissue, in plasma, and in urine was calculated front the measurement of radioactivity and the specific activity of the infused ouabain.
During the period of ouabain infusion, from 18 to 30 70 of the infused ouabain was recovered in the urine (12-24 7O from the infused kidney, and 6-7 % from the contralateral kidney). During the hour that followed the infusion, 5-6 % was recovered in the urine (2-3 % from both the infused and contralateral sides). As expected, the highest concentration of ouabain in plasma (0.145-0.44 PM) was found in the samples drawn after 55 min of infusion, i.e., just before stopping the ouabain, and this was also the time at which the excretion of ouabain by the contralateral kidney was maximal.
The peak excretion of ouabain by the infused kidney occurred lo-50 min before the end of the infusion. The clearance of ouabain in the last four urine collections (20-60 min after discontinuing ouabain) in three dogs was (mean rfi SEM) 54.7 & 10.8 and 57.9 &-13 .6% of the inulin clearance in the experimental and contralateral sides, respectively.
At the end of the experiment, 8.5-14.4% of the administered ouabain was recovered from the experimental kidney and 2.8-9.8 % from the contralateral kidney. Thus, about 25 % of the infused ouabain was excreted in the urine or attached to the infused kidney. The fact that one-fourth or more of the ouabain administered did not enter the general circulation explains the low mortality, although we were using doses that are very close to the LDSO for systemic administration of ouabain (14). The amount of ouabain attached to the infused kidney at the end of the experiment, expressed as moles per liter of tissue water, was estimated to vary from 3.4 X 10-G to 6.7 X lo-" M in the cortex, and from 6.6 X IO+ to 18.4 X 10V6 M in the outer medulla.
The quantity of ouabain bound to protein was 2.5-3.75 times greater in the outer medulla than in the cortex. In the contralateral kidney this ratio was 1.8-2.25.
The amount of ouabain bound in vivo to the cortex and outer medulla of the kidney was closely correlated ( Fig. 1 per hour (40-96 % inhibition). Inhibition was also demonstrated in the contralateral kidney in both cortex and outer medulla, though only exceptionally to the degree observed on the infused side. When the dose of ouabain was 60 pg/ kg, the activity of the enzyme observed in vitro in the infused kidney was less than 40 YO below normal in both cortex and outer medulla of two out of three dogs; in the third animal, in which no changes in the output of sodium or urine were observed during the course of the experiment, and the position of the catheter was confirmed to be in the renal artery at sacrifice, no decrease in the activity of Na-KATPase could be demonstrated.
In all the other dogs, the doses of ouabain varied from 72 to 150 pg/kg, and enzyme inhibition in the kidney infused directly with ouabain resulted in activities below one-third of the average observed in controls. Figs. 2 und 3) . The capacity of the infused kidney to concentrate urine (T&) was sharply reduced by ouabain (Fig. 2) . This occurred when glomerular filtration rate was only slightly reduced during ouabain infusion to 80 % of the control level, as well as when the reduction in GFR was more pronounced. When the in vitro Na-K-ATPase activity of the outer medulla was reduced to 10 units or less, concentrating ability was almost completely eliminated, with values for T&o below 0.1 ml/min; in 7 of 10 of these experiments, the activity of Na-K-ATPase measured in whole homogenates of outer medulla averaged only 5.6 rfi 1.13 pmoles PJmg protein per hour.
Mrhen ouabain was infused into the renal artery of dogs volume expanded with saline alone or with mannitol and saline, a considerable increase in fractional sodium excretion occurred, averaging 4 1.3 Yc of filtered sodium in five salineloaded dogs and 57.4 % in five dogs loaded more heavily with mannitol and saline ( Table 2 ). The highest fractional sodium excretion was obtained in a dog that received ouabain (100 pg/kg) d uring mannitol-saline diuresis. In this animal, Na-K-A4TPase activity in the infused kidney was 0.7 pmoles Pi/mg protein per hour in the cortex and 7.3 pmoles Pi/mg protein per hour in the outer medulla. T&,9 fell from 1.5 to 0.1 ml/min.
More than three-quarters of the filtered sodium appeared in the urine; however, 23.5 % continued to be reabsorbed. In the representative experiment shown in Table 3 , Na-K-ATPase activity of the infused kidney was inhibited to approximately 65 % of normal controls in the cortex and 79 % in the outer medulla. The percentage of filtered sodium 2 Inhibition of kidney Na-K-ATPase by the infusion of ouabain in vivo was calculated as 1 -(measured Na-K-ATPase activity) / (avg of normal dogs) X 100. 
Effect of ouabain on concentrating capacity (T&).
In all experiments, Na-K-ATPase activity in outer medulla fell to or below 10.0 pmoles Pi/mg protein per hour.
that was excreted in the urine increased from 3.6 % during mannitol-saline diuresis to 44.7 % after ouabain infusion, and T&o fell from 0.70 to 0.20 ml/min. Less marked inhibition of Na-K-ATPase, as seen in the contralateral kidney where both cortical and medullary enzyme activity was slightly below half of the average control, produced a smaller increase in fractional sodium excretion from 8.9 to 18.8 Y+ though T&9 fell markedly from 1.0 to 0.4 ml/min.
When ouabain was infused into the renal artery of three hydropenic dogs (Table  Z) , Na-K-ATPase was inhibited in the infused kidney to the same level as in the preceding experiments, but the fractional excretion of sodium attained only about half the level reached in dogs that had been prepared by mannitol-saline diuresis. Under these circumstances, the highest fractional excretion of sodium attained was 35 % in a dog in which Na-K-ATPase activity in cortex and outer medulla was 1.8 and 4.6 ,umoles P i/mg protein per hour, respectivelv. Figure 3 summarizes the diuretic effect of ouabain when Na-K-ATPase activity in the cortex was less than 2. diuresis. In the experiment detailed in Table 4 , Na-KATPase activity was considerably inhibited in cortex and medulla of the infused kidney. Fractional excretion of sodium on that side, however, never exceeded 30 YL On the contralateral side, where enzyme inhibition was less than 40 % in outer medulla and about 50 Yc in cortex, the increase in fractional sodium excretion was negligible. Free water clearance (C,,,) d iminished on the infused side from 3.1 to 1.2 ml/ min, despite an increase in solute excretion, attaining its minimal value at the same time that sodium excretion increased to a maximum.
i?fect of systemic administration of ethacrynic acid after infusion of ouabain into renal artery (Tables 5 and 6 ). In four experiments (Table  5) , 30 min after the completion of an infusion of ouabain (90 pg;kg over 1 hr), ethacrynic acid was infused intravenously at doses that have been shown to produce maximal natriuresis (1). Table 6 summarizes the observations in a representative experiment.
In this 24-kg dog undergoing saline diuresis, 30 min after the infusion of ouabain had been completed, 150 mg of ethacrynic acid were given intravenously in 3 min, followed by a sustaining infusion of 1.5 mgjmin until the end of the experiment 60 min later. A rise in fractional sodium excretion to 43 %I, comparable to that seen in other experiments during saline diuresis, was observed in the experimental kidney 30 min after the infusion of ouabain was given.
On the contralateral side, where fractional sodium excretion had risen from 12 to 20 % after ouabain, the infusion of ethacrynic acid was followed by a rise in sodium excretion to the same level observed in the experimental kidney. Nevertheless, inhibition of Na-K-ATPase in the contralateral kidney was only 30 % in the cortex and zero in the outer medulla.
This implies that ethacrynic acid produces its natriuretic effect by a mechanism independent of the inhibition of Na-K-ATPase, as suggested by Proverbio, made to explore the functional significance of Na-KATPase in the kidney by 1) trying to approach maximum inhibition of the enzyme in a kidney perfused with ouabain, while avoiding serious systemic toxicity, and r?) determining the quantitative relationship between inhibition of sodium transport and inhibition of Na-K-ATPase by ouabain. It seems likely from these experiments and others (8, 13-l 6) that Na-K-ATPase is present in the kidney in considerable excess in the sense that small degrees of inhibition do not result in massive sodium diuresis. With larger doses of ouabain and more complete inhibition, sodium reabsorption is progressively inhibited. The striking finding, however, is that even when the activity of the enzyme is very small or negligible in kidney homogenates, a substantial fraction of the glomerular filtrate continues to be reabsorbed by the tubules. For example, in a dog undergoing mannitol diuresis, in which the in vitro activity of Na-K-ATPase in kidney cortex was only 0.7 pmoles PJmg protein per hour and in outer medulla only 7.3 ,umoles P i/mg protein per hour, 23.5 % of the sodium filtered was reabsorbed.
It is, of course, possible that enzyme activity is less completely inhibited in viva than in vitro or that the tiny amount of activity persisting is responsible for the remaining reabsorptive activity in the tubules. Nevertheless, this kind of experiment suggests that Na-K-ATPase activity is necessary for only a portion of the total amount of sodium reabsorbed by the nephron.
This has also been proposed by Whittembury and Proverbio (22) Dextrose, 2 .5y0 in water, 1,000 ml iv Dextrose, 2.5% in water iv at 4 ml/min Inulin, 371 mg iv in 53 ml of dextrose 2 .5y0 in water NaCl, 0.9y0 into right renal artery at 0.5 ml/min Dextrose, 2 .5y0 in water iv at 2 ml/min Inulin, 7 mg/ml in dextrose, 2.5% in water iv at 1 ml/min pronounced inhibition reabsorption and a greater diuresis.
The -results of the present experiments, summarized in Fig. 3 , are consistent with this hypothesis.
In hydropenic dogs and in a dog undergoing water diuresis, inhibition of Na-K-ATPase to a level of lo-20 YO the activity normally found in renal cortex and medulla resulted in the excretion of 23-36 % of the filtered load of sodium on the infused side. By contrast, in dogs infused with mannitol or saline, in which ouabain inhibited Na-K-ATPase to approximately the same level, about twice as much filtered sodium, varying from 44 to 77 Yo, was now excreted. Similar findings were noted by Nelson and Nechay (16) . The discrepancy cannot be explained by differences in glomerular filtration rate, since this was altered comparably by ouabain in both groups. Both the anatomical distribution of Na-K-ATPase along the nephron and the functional results of inhibition of the enzyme in the intact kidney thus lend credence to the idea that Na-K-ATPase plays a larger role in sodium reabsorption in the distal portion of the nephron than in the proximal convolution.
noted also by Nechay et al. (15) . It would appear that whatever the mechanism is for sodium transport in the intact kidney that is resistant to ouabain, it is probably a.lso resistant to inhibition by ethacrynic acid. These results have special significance when viewed from the standpoint of the distribution of Na-K-ATPase in cortex and medulla of the kidney. The specific activity of Na-K-ATPase is considerably higher in the red medulla than in the cortex (7) and much higher in the ascending limb of the loop of Henle and the distal convolution than in the proximal convoluted tubule ( 18). It is not surprising, therefore, that the ability of the kidneys to excrete a concentrated urine was partially eliminated by blocking doses of intra-arterial ouabain and that diluting ability was also impaired.
Similar, though less striking, impairment of concentrating and diluting ability was reported recently by , who infused digoxin into the renal artery of dogs. Such experiments suggest that the Na-K-ATPase present in the thick ascending limb plays a critical role in the reabsorption of sodium in this portion of the tubule. This conclusion is consistent with the earlier paper of Wilde and Howard (23) , who surmised from stop-flow experiments that ouabain impaired sodium reabsorption in the distal tubule. If Na-K-ATP ase played a major role in sodium reabsorption in the distal tubule but a lesser role in the proximal, it should be possible to vary the diuretic effect of ouabain by apportioning the reabsorptive load in different ways between the proximal and distal tubules before giving the inhibitor.
If the stage were set by hydropenia, when approximately 60 % of glomerular filtrate is reabsorbed in the proximal tubule (4), ouabain might be expected to block
